See more : Athene Holding Ltd. (ATHLV) Income Statement Analysis – Financial Results
Complete financial analysis of EXMceuticals Inc. (EXM.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of EXMceuticals Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- COSCO SHIPPING Holdings Co., Ltd. (CICOY) Income Statement Analysis – Financial Results
- CMS Energy Corporation 5.875% J (CMSC) Income Statement Analysis – Financial Results
- Rapac Communication & Infrastructure Ltd (RPAC.TA) Income Statement Analysis – Financial Results
- SCG Packaging Public Company Limited (5Y7A.F) Income Statement Analysis – Financial Results
- Metso Outotec Oyj (OUKPY) Income Statement Analysis – Financial Results
EXMceuticals Inc. (EXM.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://exmceuticals.com
About EXMceuticals Inc.
EXMceuticals Inc. engages in the production of cannabinoid formulations. The company primarily focuses around the matching of natural bioactive ingredients extracted from the cannabis plant with the needs of the nutraceutical, cosmeceutical, therapeutic, and pharmaceutical industries. It focuses on the production of CBD, a non-psychoactive cannabinoid that has been proven effective against acne, anxiety, depression, epilepsy, and degenerative diseases, such as Parkinson's; and THC, a psychoactive cannabinoid ingredient that has been proven effective in the fields of pain management, appetite control, anxiety, and managing side effects of chemotherapy. The company was incorporated in 2008 and is headquartered in Quebec, Canada.
| Metric | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 39.59 | 617.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -39.59 | -617.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.78M | 8.55M | 1.02K | 308.52 | 304.25K | 95.83K | 92.57K | 89.23K | 103.89K | 194.48K | 57.42K |
| Selling & Marketing | 468.03K | 563.29K | 18.33K | 61.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 27.50K | 878.00 |
| SG&A | 7.25M | 9.12M | 1.32K | 370.26 | 304.25K | 95.83K | 92.57K | 89.23K | 103.89K | 221.98K | 58.30K |
| Other Expenses | 606.60K | 629.52K | 0.00 | 100.00 | 144.00 | 180.00 | 180.00 | 404.00 | 5.65K | 403.00 | 208.20K |
| Operating Expenses | 7.86M | 9.75M | 1.32K | 370.26 | 304.39K | 96.01K | 92.75K | 89.63K | 109.54K | 222.38K | 266.50K |
| Cost & Expenses | 7.86M | 9.75M | -1.32K | -370.26 | 304.39K | 96.01K | 92.75K | 89.63K | 109.54K | 222.38K | 266.50K |
| Interest Income | 703.00 | 0.00 | 4.01K | 0.00 | 0.00 | 43.00 | 0.00 | 1.61K | 3.23K | 3.18K | 0.00 |
| Interest Expense | 553.49K | 13.65K | 11.40K | 0.00 | 1.35K | 3.44K | 487.00 | 343.00 | 185.00 | 56.00 | 57.00 |
| Depreciation & Amortization | 139.10K | 161.14K | -55.18K | 100.00 | 144.00 | 180.00 | 180.00 | 404.00 | 403.00 | 403.00 | 202.00 |
| EBITDA | -7.74K | -9.75M | -0.52 | 0.00 | -494.11K | -205.27K | -93.16K | -89.28K | -233.76K | -598.58K | -266.30K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -7.86M | -9.75M | -1.32K | -370.26 | -304.95K | -96.01K | -92.75K | -90.98K | -109.73K | -222.44K | -266.50K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 7.85M | -82.39K | -0.52 | 0.00 | -190.66K | -112.89K | -1.08K | 946.00 | -124.62K | -376.60K | -57.00 |
| Income Before Tax | -9.93M | -9.83M | -1.32K | -370.26 | -495.61K | -208.89K | -93.82K | -90.03K | -234.34K | -599.04K | -266.56K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -121.86K | -71.41K | -0.52 | -2.91K | -189.31K | -109.44K | -590.00 | 1.29K | -124.43K | -87.18K | -18.67K |
| Net Income | -9.81M | -9.76M | -1.32K | -370.26 | -495.61K | -208.89K | -93.82K | -90.03K | -234.34K | -511.85K | -247.89K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.25 | -0.43 | -0.49 | 0.00 | -0.04 | -0.06 | -0.03 | -0.03 | -0.08 | -0.18 | -0.30 |
| EPS Diluted | -0.25 | -0.43 | -0.49 | 0.00 | -0.04 | -0.06 | -0.03 | -0.03 | -0.08 | -0.18 | -0.30 |
| Weighted Avg Shares Out | 39.58M | 22.80M | 2.68K | 13.85M | 11.76M | 3.45M | 3.12M | 3.05M | 3.02M | 2.78M | 819.86K |
| Weighted Avg Shares Out (Dil) | 39.58M | 22.80M | 2.68K | 13.85M | 11.76M | 3.45M | 3.12M | 3.05M | 3.02M | 2.78M | 819.86K |
Source: https://incomestatements.info
Category: Stock Reports